Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki
Alexandre P
AP
Soares
Fabiana C
FC
Superti
Silvana V
SV
Silbert
Suzane
S
Silva
Fernanda M
FM
Barth
Afonso L
AL
D000150:Acinetobacter / Q000187:drug effects* / Q000302:isolation & purification*; D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001938:Brazil; D015780:Carbapenems / Q000494:pharmacology* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D015780:Carbapenems